Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Addressing Barriers to Transitioning Pediatric Patients With Epilepsy to Adult Health Care in the United States: A Narrative Review.
Journal: Neurology. Clinical practice
Published: May 11, 2026
Effectiveness and safety of perampanel by concomitant antiseizure medications: Insights from the real-world PERMIT Extension study.
Journal: Epilepsy & behavior : E&B
Published: May 22, 2025
Exploring proposed recommendations for immediate-use seizure medication: Treating both cluster and prolonged seizures with diazepam nasal spray.
Journal: Epilepsia open
Published: December 03, 2024
Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher-level emergency: Consensus recommendations of an expert working group.
Journal: Epileptic disorders : international epilepsy journal with videotape
Published: February 15, 2024
Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study.
Journal: Epilepsy & behavior : E&B
Published: May 30, 2023
Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
Journal: Seizure
Published: March 30, 2023
Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program.
Journal: Epilepsia
Published: December 22, 2022
Overcoming presynaptic effects of VAMP2 mutations with 4-aminopyridine treatment.
Journal: Human mutation
Published: June 04, 2020
Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
Journal: Epilepsy research
Published: January 15, 2019
A Randomized, Placebo-Controlled, Blinded, Crossover, Pilot Study of the Effects of Dextromethorphan/Quinidine for the Treatment of Neurobehavioral Symptoms in Adults with Autism.
Journal: Journal of autism and developmental disorders
Published: August 16, 2018
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders.
Journal: Nature communications
Published: July 30, 2018
Last Updated: 09/26/2026